Evidence map›Paper›PMID 37059315›Full record

ArticleBone2023

X-linked hypophosphatemia in 4 generations due to an exon 13-15 duplication in PHEX, in the absence of the c.*231A>G variant.

Julio Soto Barros, Sabrina I Sanchez, Kristin Cabral, Alan H Beggs, Pankaj B Agrawal, Casie A Genetti, Catherine A Brownstein, Thomas O Carpenter

Open access · greenAbstract read
In one paragraph

Article in Bone, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. UnusualJBMR plus · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Julio Soto BarrosDepartment of Pediatrics, Faculty of Medicine, University of Concepcion, Concepcion, Chile; Las Higueras Hospital, Talcahuano, Chile; Yale Center for X-Linked Hypophosphatemia, Department of Pediatrics (Endocrinology), Yale University, New Haven, CT 06519, United States of America.
Sabrina I SanchezManton Center for Orphan Disease Research, Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, United States of America.
Kristin CabralManton Center for Orphan Disease Research, Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, United States of America.
Alan H BeggsManton Center for Orphan Disease Research, Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, United States of America; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, United States of America.
Pankaj B AgrawalManton Center for Orphan Disease Research, Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, United States of America; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, United States of America; Division of Neonatology, Department of Pediatrics, University of Miami Miller School of Medicine and Holtz Children's Hospital, Jackson Health System, Miami, FL 33136, United States of America.
Casie A GenettiManton Center for Orphan Disease Research, Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, United States of America.
Catherine A BrownsteinManton Center for Orphan Disease Research, Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, United States of America; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, United States of America.
Thomas O CarpenterYale Center for X-Linked Hypophosphatemia, Department of Pediatrics (Endocrinology), Yale University, New Haven, CT 06519, United States of America. Electronic address: thomas.carpenter@yale.edu.
Boston Children's Hospital · USUniversity of Concepción · CLYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
NCATS NIH HHS UL1 TR001863NICHD NIH HHS U54 HD090255
6 · The paper itself

Abstract

X-linked hypophosphatemia is the most common cause of inherited rickets, due to inactivating variants of PHEX. More than 800 variants have been described to date and one which consists of a single base change in the 3' untranslated region (UTR) (c.*231A>G) is reported as prevalent in North America. Recently an exon 13-15 duplication has been found to occur in concert with the c.*231A>G variant, and thus it is unclear whether the pathogenicity is solely a function of the UTR variant. We present a family with XLH who harbors the exon 13-15 duplication but does not carry the 3'UTR variant, providing evidence that the duplication itself is the pathogenic variant when these two variants are found in cis.

Indexed as

Familial Hypophosphatemic RicketsGenetic Diseases, X-LinkedHypophosphatemia3' Untranslated RegionsExonsHumansMutationPHEX Phosphate Regulating Neutral Endopeptidase3' Untranslated RegionsPHEX Phosphate Regulating Neutral EndopeptidasePHEX protein, humanPhosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX)RicketsX-linked hypophosphatemia (XLH)

Identifiers

PMID37059315
PMCPMC10198939
OpenAlexW4365811175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.